Comparison of Suprachoroidal Drug Delivery with Subconjunctival and Intravitreal Routes Using Noninvasive Fluorophotometry

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Tyagi, Puneet ^a   Kadam, Rajendra S ^a   Kompella, Uday B ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c University of Colorado at Denver   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN SODIUM; INDIAN INK;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CHOROID; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; FEASIBILITY STUDY; FLUOROPHOTOMETER; FLUOROPHOTOMETRY; HISTOLOGY; INTRAVITREAL DRUG ADMINISTRATION; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHOTOMETER; POSTERIOR EYE CHAMBER; RAT; RETINA; SUBCONJUNCTIVAL DRUG ADMINISTRATION; SUPRACHOROIDAL DRUG ADMINISTRATION; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION PROCESS;

ANIMALS; AREA UNDER CURVE; CARBON; CHOROID; FLUORESCEIN; FLUORESCENT DYES; FLUOROPHOTOMETRY; INJECTIONS, INTRAOCULAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; RETINA; VITREOUS BODY;

RATTUS;

EID: 84868292495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048188     Document Type: Article

References (44)

1. Jager RD, Mieler WF, Miller JW, (2008) Age-related macular degeneration. N Engl J Med 358: 2606-2617.
2. Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, et al. (2008) Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol 126: 1740-1747.
3. Smiddy WE, (2007) Relative cost of a line of vision in age-related macular degeneration. Ophthalmology 114: 847-854.
4. Lee VH, Robinson JR, (1986) Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol 2: 67-108.
5. Shelke NB, Kadam RS, Tyagi P, Rao VR, Kompella UB, (2011) Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases. Drug Delivery and Translational Research 1: 76-90.
6. Anderson OA, Bainbridge JW, Shima DT, (2010) Delivery of anti-angiogenic molecular therapies for retinal disease. Drug Discov Today 15: 272-282.
7. Jonas JB, Spandau UH, Schlichtenbrede F, (2008) Short-term complications of intravitreal injections of triamcinolone and bevacizumab. Eye (Lond) 22: 590-591.
8. Amrite AC, Ayalasomayajula SP, Cheruvu NP, Kompella UB, (2006) Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest Ophthalmol Vis Sci 47: 1149-1160.
9. Amrite AC, Edelhauser HF, Singh SR, Kompella UB, (2008) Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis 14: 150-160.
10. Raghava S, Hammond M, Kompella UB, (2004) Periocular routes for retinal drug delivery Expert Opin Drug Deliv. 1: 99-114.
11. Cheruvu NP, Ayalasomayajula SP, Kompella UB (2003) Retinal Delivery of Sodium Fluorescein, Budesonide & Celecoxib Following Subconjunctival Injection. Drug Development & Delivery 3.
12. Negi AK, Browning AC, Vernon SA, (2006) Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: Randomized controlled trial. J Cataract Refract Surg 32: 468-474.
13. Krohn J, Bertelsen T, (1997) Corrosion casts of the suprachoroidal space and uveoscleral drainage routes in the human eye. Acta Ophthalmol Scand 75: 32-35.
14. Einmahl S, Savoldelli M, D'Hermies F, Tabatabay C, Gurny R, et al. (2002) Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci 43: 1533-1539.
15. Poole TA, Sudarsky RD, (1986) Suprachoroidal implantation for the treatment of retinal detachment Ophthalmology. 93: 1408-1412.
16. Olsen TW, Feng X, Wabner K, Conston SR, Sierra DH, et al. (2006) Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment. Am J Ophthalmol 142: 777-787.
17. Patel SR, Lin AS, Edelhauser HF, Prausnitz MR, (2011) Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res 28: 166-176.
18. Olsen TW, Feng X, Wabner K, Csaky K, Pambuccian S, et al. (2011) Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model. Invest Ophthalmol Vis Sci 52: 4749-4756.
19. Ghate D, Brooks W, McCarey BE, Edelhauser HF, (2007) Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci 48: 2230-2237.
20. Lee SJ, Kim ES, Geroski DH, McCarey BE, Edelhauser HF, (2008) Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes. Invest Ophthalmol Vis Sci 49: 4506-4514.
21. Berezovsky DE, Patel SR, McCarey BE, Edelhauser HF, (2011) In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits. Invest Ophthalmol Vis Sci 52: 7038-7045.
22. Das T, Vedantham V, (2004) Intravitreal sodium fluorescein enhances visualization of clear vitreous during vitreous surgery for macular hole: a safety and efficacy study. Clin Experiment Ophthalmol 32: 55-57.
23. Sjoback R, Nygren J, Kubista M, (1995) Absorption and fluorescence properties of fluorescein. Spectrochimica Acta Part A 51: L7-L21.
24. Park JH, Lee YC, Lee SY, (2009) The comparison of mydriatic effect between two drugs of different mechanism. Korean J Ophthalmol 23: 40-42.
25. Raines MF, (1988) Vitreous fluorophotometry: a review. J R Soc Med 81: 403-406.
26. Ishiko S, Yoshida A, Kitaya N, Abiko T, Mori F, et al. (1996) Fluorophotometry with a small animal adapter. Jpn J Ophthalmol 40: 310-316.
27. Eldred GE, Miller GV, Stark WS, Feeney-Burns L, (1982) Lipofuscin: resolution of discrepant fluorescence data. Science 216: 757-759.
28. Fariss RN, Apte SS, Olsen BR, Iwata K, Milam AH, (1997) Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J Pathol 150: 323-328.
29. Van Schaik HJ, Alkemade C, Swart W, Van Best JA, (1999) Autofluorescence of the diabetic and healthy human cornea in vivo at different excitation wavelengths. Exp Eye Res 68: 1-8.
30. Katz ML, Robison WG Jr, Herrmann RK, Groome AB, Bieri JG, (1984) Lipofuscin accumulation resulting from senescence and vitamin E deficiency: spectral properties and tissue distribution. Mech Ageing Dev 25: 149-159.
31. Tsubota K, Laing RA, Kenyon KR, (1987) Noninvasive measurements of pyridine nucleotide and flavoprotein in the lens. Invest Ophthalmol Vis Sci 28: 785-789.
32. Lee SM, Schade SZ, Doughty CC, (1985) Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens. Biochim Biophys Acta 841: 247-253.
33. Batey DW, Daneshgar KK, Eckhert CD, (1992) Flavin levels in the rat retina. Exp Eye Res 54: 605-609.
34. Gray JR, Mosier MA, Ishimoto BM, (1985) Optimized protocol for Fluorotron Master. Graefes Arch Clin Exp Ophthalmol 222: 225-229.
35. Araie M, Maurice DM, (1991) The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways. Exp Eye Res 52: 27-39.
36. Maurice DM (1976) Injection of the drugs in the vitreous body. In Symposium on Ocular Therapy, Leopold IH, Burns RP eds., John Wiley and Sons, Inc., New York, 59-71.
37. Robinson MR, Lee SS, Kim H, Kim S, Lutz RJ, et al. (2006) A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Exp Eye Res 82: 479-487.
38. Seiler GS, Salmon JH, Mantuo R, Feingold S, Dayton PA, et al. (2011) Effect and distribution of contrast medium after injection into the anterior suprachoroidal space in ex vivo eyes. Invest Ophthalmol Vis Sci 52: 5730-5736.
39. Polska E, Polak K, Luksch A, Fuchsjager-Mayrl G, Petternel V, et al. (2004) Twelve hour reproducibility of choroidal blood flow parameters in healthy subjects. Br J Ophthalmol 88: 533-537.
40. Bradley SE, Ingelfinger FJ, Bradley GP, Curry JJ, (1945) The Estimation of Hepatic Blood Flow in Man. J Clin Invest 24: 890-897.
41. Hubner GH, Steudel N, Kleber G, Behrmann C, Lotterer E, (2000) Hepatic arterial blood flow velocities: assessment by transcutaneous and intravascular Doppler sonography. J Hepatol 32: 893-899.
42. Friedman E, Kopald HH, Smith TR, (1964) Retinal and Choroidal Blood Flow Determined with Krypton-85 Anesthetized Animals. Invest Ophthalmol Vis Sci 3: 539-547.
43. Carlisle KM, Halliwell M, Read AE, Wells PN, (1992) Estimation of total hepatic blood flow by duplex ultrasound. Gut 33: 92-97.
44. Riedel J (2006) Distribution-in vitro tests-protein binding. In Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, Vogel GH, Hock FJ, Maas J, Mayer D eds., Springer Berlin Heidelberg, 473-486.